88R10180 MCF-D
By: Tinderholt H.B. No. 4754
A BILL TO BE ENTITLED
AN ACT
relating to health benefit plan coverage for and prohibitions on
gender transitioning procedures and treatments provided to certain
individuals; creating a criminal offense.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. This Act may be cited as the Texas Millstone Act.
SECTION 2. Chapter 161, Health and Safety Code, is amended
by adding Subchapter X to read as follows:
SUBCHAPTER X. GENDER TRANSITION PROCEDURES OR TREATMENTS
Sec. 161.701. DEFINITIONS. In this subchapter:
(1) "Biological sex" means the biological indication
of male or female in the context of reproductive potential or
capacity, such as sex chromosomes, naturally occurring sex
hormones, gonads, and nonambiguous internal and external genitalia
present at birth, without regard to an individual's psychological,
chosen, or subjective experience of gender.
(2) "Cross-sex hormones" means:
(A) testosterone or other androgens provided to a
biological female in a more potent amount than would naturally
occur in a healthy biological female; or
(B) estrogen provided to a biological male in a
more potent amount than would naturally occur in a healthy
biological male.
(3) "Gender" means the psychological, behavioral,
social, and cultural aspects of being male or female.
(4) "Gender reassignment surgery" means a medical
procedure performed for the purpose of surgically altering or
removing healthy anatomical characteristics typical for the
individual's biological sex to instill physiological or anatomical
characteristics that resemble a sex different than the individual's
biological sex. The term includes genital or nongenital gender
reassignment surgery performed for the purpose of assisting an
individual with a gender transition.
(5) "Gender transition" means the process by which an
individual progresses from identifying with and living as the
gender that corresponds to the individual's biological sex to
identifying with and living as a gender different than the
individual's biological sex. The term includes social, legal, or
physical changes to an individual.
(6) "Gender transition procedure or treatment" means a
medical or surgical procedure or treatment, including a physician's
services, inpatient and outpatient hospital services, and
prescription drugs, related to gender transition that seeks to:
(A) alter or remove anatomical characteristics
typical for the individual's biological sex; or
(B) instill physiological or anatomical
characteristics that resemble a sex different from the individual's
biological sex, including:
(i) medical services that provide
puberty-blocking drugs, cross-sex hormones, or other mechanisms to
promote the development of feminizing or masculinizing features in
the opposite biological sex; and
(ii) genital or nongenital gender
reassignment surgery performed for the purpose of assisting an
individual with a gender transition.
(7) "Genital gender reassignment surgery" means a
medical procedure related to an individual's genitals and performed
for the purpose of assisting the individual with a gender
transition, including:
(A) surgical procedures such as penectomy,
orchiectomy, vaginoplasty, clitoroplasty, or vulvoplasty for
biologically male patients or hysterectomy or oophorectomy for
biologically female patients;
(B) reconstruction of the fixed part of the
urethra with or without a metoidioplasty; or
(C) phalloplasty, vaginectomy, scrotoplasty, or
implantation of erection or testicular prostheses for biologically
female patients.
(8) "Health care professional" means an individual
other than a physician who is licensed, certified, or otherwise
authorized by this state's laws to administer health care in the
ordinary course of business or practice of a profession.
(9) "Nongenital gender reassignment surgery" means a
medical procedure that is not a genital gender reassignment surgery
and is performed for the purpose of assisting an individual with a
physical gender transition, including the following surgical
procedures:
(A) for either a biological male or female:
(i) liposuction or lipofilling; or
(ii) various aesthetic procedures;
(B) for a biological male:
(i) augmentation mammoplasty;
(ii) facial feminization surgery;
(iii) voice feminization surgery;
(iv) thyroid cartilage reduction;
(v) gluteal augmentation; or
(vi) hair reconstruction; or
(C) for a biological female:
(i) subcutaneous mastectomy;
(ii) voice masculinization surgery; or
(iii) pectoral implants.
(10) "Physician" means a person licensed to practice
medicine in this state.
(11) "Puberty-blocking drug" means a drug used to
delay or suppress normal puberty development in children for the
purpose of assisting an individual with a gender transition,
including:
(A) for a biological male, a
gonadotropin-releasing hormone analogue or other synthetic drug
prescribed to stop luteinizing hormone secretion and testosterone
secretion; or
(B) for a biological female, a synthetic drug
prescribed to stop the production of estrogen and progesterone.
(12) "Public money" means money of this state, a state
agency, or a political subdivision.
Sec. 161.702. APPLICABILITY. This subchapter does not
apply to:
(1) a procedure, treatment, or service provided to an
individual who is born with a medically verifiable genetic disorder
of sex development, including:
(A) 46,XX chromosomes with virilization;
(B) 46,XY chromosomes with undervirilization; or
(C) both ovarian and testicular tissue;
(2) a procedure, treatment, or service provided to an
individual who does not have the normal sex chromosome structure,
sex steroid production, or sex steroid hormone action for male or
female as determined by a physician through genetic testing or
biochemical testing;
(3) treatment of an infection, injury, disease, or
disorder that has been caused by or exacerbated by the performance
of a gender transition procedure or treatment, regardless of
whether:
(A) the gender transition procedure or treatment
was performed in accordance with state and federal law; or
(B) funding for the gender transition procedure
or treatment is permissible under this subchapter; or
(4) a procedure undertaken because the individual
suffers from a physical disorder, injury, or illness that would, as
certified by a physician, place the individual in imminent danger
of death or impairment of a major bodily function unless the
procedure is performed.
Sec. 161.703. CONSTRUCTION OF SUBCHAPTER. This subchapter
may not be construed to deny, impair, or otherwise affect any right
or authority of the attorney general, this state, or any agency,
officer, or employee of this state, acting under any law other than
this subchapter, to bring or intervene in an action brought under
this subchapter.
Sec. 161.704. PROHIBITED PROVISION OF GENDER TRANSITION
PROCEDURES OR TREATMENTS. A physician or health care professional,
including a physician or health care professional employed by or
practicing in a facility owned by this state or a political
subdivision, may not:
(1) provide a gender transition procedure or treatment
to an individual younger than 26 years of age; or
(2) refer an individual younger than 26 years of age to
a physician or health care professional for a gender transition
procedure or treatment.
Sec. 161.705. PROHIBITED USE OF PUBLIC MONEY. Public money
may not directly or indirectly be used, granted, paid, or otherwise
distributed to a person who provides gender transition procedures
or treatment to individuals younger than 26 years of age.
Sec. 161.706. PROHIBITED MEDICAID REIMBURSEMENT. The
commission may not provide Medicaid reimbursement to a provider for
a gender transition procedure or treatment to an individual younger
than 26 years of age.
Sec. 161.707. CRIMINAL OFFENSE. (a) A physician or health
care professional who knowingly violates Section 161.704 commits an
offense.
(b) An offense under this section is a state jail felony.
(c) An indictment for an offense under this section must be
presented within 40 years from the date of the commission of the
offense, and not afterward.
Sec. 161.708. DISCIPLINARY ACTION. (a) The Texas Medical
Board or another state regulatory agency with jurisdiction over a
health care provider subject to Section 161.704 shall revoke the
license, certification, or authorization of a physician or health
care provider who the board or agency determines has violated that
section.
(b) Disciplinary action described by Subsection (a) must be
taken not later than the 40th anniversary of the date of the
violation of Section 161.704.
Sec. 161.709. CIVIL ACTION. (a) Notwithstanding any other
law, an individual may bring an action for damages incurred as a
result of a gender transition procedure or treatment performed on
the individual:
(1) through the individual's parent, guardian, or next
friend, if the individual is under 18 years of age; and
(2) in the individual's own name, not later than the
40th anniversary after the date the individual attains 18 years of
age.
(b) A court may award to the prevailing claimant:
(1) compensatory damages;
(2) injunctive relief;
(3) declaratory relief; and
(4) any other appropriate relief.
(c) A court shall award a claimant prevailing in an action
brought under this section reasonable attorney's fees incurred in
bringing the action.
(d) Notwithstanding any other law, an action brought under
this section may be commenced, and relief may be granted, in a
judicial proceeding without regard to whether the individual
commencing the action has sought or exhausted available
administrative remedies.
Sec. 161.710. ATTORNEY GENERAL ENFORCEMENT. (a) The
attorney general may bring an action to enforce this subchapter.
(b) In an action brought under this section, the court may
award the attorney general injunctive or declaratory relief and
reasonable attorney's fees and costs incurred in bringing the
action.
SECTION 3. If before implementing any provision of this Act
a state agency determines that a waiver or authorization from a
federal agency is necessary for implementation of that provision,
the agency affected by the provision shall request the waiver or
authorization and may delay implementing that provision until the
waiver or authorization is granted.
SECTION 4. This Act takes effect September 1, 2023.